GOSS Gossamer Bio Inc

H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Gossamer Bio (GOSS - Research Report) today and set a price target of $25.00. The company's shares closed yesterday at $11.74.Trucchio covers the Healthcare sector, focusing on stocks such as Alnylam Pharma, Gossamer Bio, and Immunocore Holdings. According to TipRanks, Trucchio has an average return of -15.7% and a 30.82% success rate on recommended stocks. Gossamer Bio has an analyst consensus of Strong Buy, with a price target consensus of $19.50.See Insiders’ Hot Stocks on TipRanks >> Based on Gossamer Bio's latest earnings release for the quarter ending June 30, the company reported a quarterly GAAP net loss of $56.
https://www.tipranks.com/news/blurbs/gossamer-bio-goss-gets-a-buy-from-h-c-wainwright?utm_source=advfn.com&utm_medium=referral